Member Info for cmww2014

Botswana has a HIV prevalence of ~25%
Much of the population will be on protease inhibitors
Do people think this is the catalyst for variant production ?
The Pfizer pill being a similar design to the HIV ones could cause concern if so ?

563 posts in the last 30 days.
Those who speak the loudest ...

Does 'converting the CFDs' mean buying the shares from the other brokers.

Would love to know what they paid !

Sharedealer, where is your intel coming from ... a good few predictions made of late, bravo sir !

https://youtu.be/E10Bp_mPXXA

... this time next month Rodney ...

Fuzz lightyear ?

He certainly looks relaxed.

The guy on zoom is a thrill a minute !

HPHQ; I managed to register okay - check you didn't put a space after your email or something ?

Are Syneos involves in the trial ?
I noticed a 'like' beneath the linkedIn update and they seem the ideal partner to get the data analysed quickly and the product to market.

Sakura what was your thoughts on the Phase 2 data?

No turkey for the statos; keep on crunching!

22 Covid patients at the India hospital now, up from 18 last week

https://pgimer.edu.in/PGIMER_PORTAL/PGIMERPORTAL/GlobalPages/JSP/covidDashboardyy.jsp

Those numbers are insane !
~$50K for a noncomplex admission; having your oxygen measured for a few days
Get SNG to them soooon !

Agree, unfortunately driving so missed the top up in the 160s 1k shares at 179 will do though

From the Dutch hospital:
After a relatively quiet period in the summer, the influx of COVID patients is now also increasing very quickly in our hospital. In both Harderwijk and Lelystad, we will make every effort in the coming period to continue our regular care as much as possible.
Good news for trial completion and hopefully the health of these people.

18 Covid patients in the Indian hospital currently.
https://pgimer.edu.in/PGIMER_PORTAL/PGIMERPORTAL/GlobalPages/JSP/covidDashboardyy.jsp

The classic throw it out there, see what the response is and revoke if necessary strategy.

I mean this sounds risky:
In effect, molnupiravir exerts its antiviral action against SARS-CoV-2 by lethal mutagenesis.